✦ LIBER ✦

Functional Lung Avoidance Using Ventilation SPECT in the Treatment of Advanced-Stage Carcinoma of the Lung: A Treatment Planning and Feasibility Study

✍ Scribed by Lukovic, J.; Yaremko, B.; Reid, R.R.

Book ID: 127140995
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 55 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.780

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy planning complexity and sur

Radiotherapy planning complexity and survival after treatment of advanced stage lung cancer in the elderly

✍ Benjamin Goldsmith; Jamie Cesaretti; Juan P. Wisnivesky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Treatment and planning decisions in non-

Treatment and planning decisions in non-small cell carcinoma of the lung: An Australasian patterns of practice study

✍ C.S. Hamilton; J.W. Denham; D.J. Joseph; D.S. Lamb; N.A. Spry; A.J. Gray; C.H. A 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 744 KB

Treatment and planning decisions in non-

Treatment and planning decisions in non-small cell carcinoma of the lung - An Australasian patterns of practice study

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase II study of gemcitabine plus ora

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Tony S. K. Mok; Benny Zee; Anthony T. C. Chan; Winnie Yeo; Wei Tse Yang; Anthony 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

Docetaxel in combination with carboplati

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study

✍ T. Giannakakis; N. Ziras; S. Kakolyris; D. Mavroudis; N. Androulakis; S. Agelaki 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Cisplatin, etoposide, and mitomycin in t

Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study

✍ Stephen Davis; Maurizio Tomato; Lucio Crino; Mari Antonetta Colozza; Kenneth Lub 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

A total of 39 patients with non-small cell carcinoma of the lung (NSCL) were treated with cisplatin, etoposide, and mitomycin. A major response rate (complete response + partial response) was seen in 15 patients (39%). Median survival for all patients was 340 days; median survival of the responding